Loading insider details...
Latest Form 4 (Aug 18, 2026): Exercise/Conversion of 4,750 CNSP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | CNS Pharmaceuticals, Inc. (CNSP) | Exercise/Conversion | 4,750 | n/a |
| Jan 2, 2026 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 19,000 | n/a |